Berger may be adept in his field and developing drugs, but I doubt he has ever cared about shareholder value. Long term holding may be well worth the wait, but we got there once and were pummeled with the FDA drawdown. Now we wait for some news that will start a secure uptrend. We are not there and now the 6's appear possible and maybe likely. With the overall market skittish, we surely need some valuable news to get this stock going. I still cannot believe we are under 8 and could not hold such. Dog.
"shareholder value" creation is not a direct, easily characterized activity, as in "I'm going to build a brick wall, and I'm going to need 1800 bricks, and at the rate of 200 bricks a day, it will take 9 days".
No, it's a secondary effect, the primary activity is a very high level of scientific competence and ultimately clinical proof of efficacy. The fact the commercial success depends on scientific and clinical work means that you cannot specify and implement "success" in a predictable way.
It's interesting to note that had the corrupt, self-aggrandizing FDA not hammered the company, Dr.Berger would be a hero today. Same guy, same application of effort and talent, but a very different situation, and one beyond Dr.Berger's control. So add the unpredictability of the Pazdur/FDA roulette to the inherent uncertainties of scientific research, and you get what you get.
I think Dr.Berger (and a top notch scientific team, put together and lead by him) did an incredible job, and it's just a bit distasteful (to me at least) to have anonymous critics pi**ing on him incessantly.
Probably a lot less than some midlevel executive in a national pizza chain whose research efforts are limited to how much mozzarella to put on the daily special.
I guess that means that you don't agree with me??? LOL!